首页 > 最新文献

Jama-Journal of the American Medical Association最新文献

英文 中文
Over Half of US Pneumonia Diagnoses Are Changed From Intake to Discharge. 美国半数以上的肺炎诊断从入院到出院都有变更。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.15889
Samantha Anderer
{"title":"Over Half of US Pneumonia Diagnoses Are Changed From Intake to Discharge.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.15889","DOIUrl":"10.1001/jama.2024.15889","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thirty-Year Trends in Perioperative Mortality Risk for Living Kidney Donors. 活体肾脏捐献者围手术期死亡率风险的三十年趋势。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.14527
Allan B Massie, Jennifer D Motter, Jon J Snyder, Macey L Levan, Dorry L Segev
{"title":"Thirty-Year Trends in Perioperative Mortality Risk for Living Kidney Donors.","authors":"Allan B Massie, Jennifer D Motter, Jon J Snyder, Macey L Levan, Dorry L Segev","doi":"10.1001/jama.2024.14527","DOIUrl":"10.1001/jama.2024.14527","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11359088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicare Advantage Has Become Notorious for Prior Authorization-CMS and Lawmakers Are Taking Action. 医疗保险优势计划因优先授权而声名狼藉--医疗保险计划和立法者正在采取行动。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.13383
Eli Cahan
{"title":"Medicare Advantage Has Become Notorious for Prior Authorization-CMS and Lawmakers Are Taking Action.","authors":"Eli Cahan","doi":"10.1001/jama.2024.13383","DOIUrl":"10.1001/jama.2024.13383","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Is Pertussis? 什么是百日咳?
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.9049
Elizabeth Scruggs-Wodkowski, Preeti Malani
{"title":"What Is Pertussis?","authors":"Elizabeth Scruggs-Wodkowski, Preeti Malani","doi":"10.1001/jama.2024.9049","DOIUrl":"10.1001/jama.2024.9049","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal Cell Carcinoma: A Review. 肾细胞癌:综述。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.12848
Tracy L Rose, William Y Kim

Importance: Renal cell carcinoma (RCC) is a common malignancy, with an estimated 434 840 incident cases worldwide in 2022. In the US, it is the sixth most common cancer among males and ninth among females.

Observations: Clear cell RCC is the most common histologic subtype (75%-80% of cases) and is characterized by inactivation of the von Hippel Lindau (VHL) tumor suppressor gene. Many patients (37%-61%) are diagnosed with RCC incidentally on an abdominal imaging study such as ultrasound or computed tomographic scan, and 70% of patients have stage I RCC at diagnosis. Although its incidence has increased approximately 1% per year from 2015 through 2019, the mortality rate of RCC has declined about 2% per year in the US from 2016 through 2020. Patients with a solid renal mass or complex cystic renal mass should be referred to urology. Treatment options for RCC confined to the kidney include surgical resection with partial or radical nephrectomy, ablative techniques (eg, cryoablation, radiofrequency ablation, radiation), or active surveillance for some patients (especially those with renal masses <2 cm). For patients with renal masses less than 4 cm in size (48% of patients), partial nephrectomy can result in a 5-year cancer-specific survival of more than 94%. For advanced or metastatic RCC, combinations of immune checkpoint inhibitors or the combination of immune checkpoint inhibitors with tyrosine kinase inhibitors are associated with tumor response of 42% to 71%, with a median overall survival of 46 to 56 months.

Conclusions and relevance: RCC is a common malignancy that is often diagnosed incidentally on an abdominal imaging study. Seventy percent of patients are diagnosed with stage I RCC and 11% of patients with stage IV. First-line treatments for early-stage RCC are partial or radical nephrectomy, which can result in 5-year cancer-specific survival of more than 94%, ablative techniques, or active surveillance. New treatment options for patients with metastatic RCC include immune checkpoint inhibitors and tyrosine kinase inhibitors.

重要性:肾细胞癌(RCC)是一种常见的恶性肿瘤,据估计,2022 年全球将出现 434 840 例病例。在美国,它是男性中第六大最常见癌症,女性中第九大最常见癌症:透明细胞型 RCC 是最常见的组织学亚型(占 75%-80% 的病例),其特点是 von Hippel Lindau(VHL)抑癌基因失活。许多患者(37%-61%)是在超声波或计算机断层扫描等腹部成像检查中偶然被诊断出患有 RCC,其中 70% 的患者在确诊时已是 I 期 RCC。虽然从 2015 年到 2019 年,RCC 的发病率每年增长约 1%,但从 2016 年到 2020 年,美国的 RCC 死亡率每年下降约 2%。有实性肾肿块或复杂囊性肾肿块的患者应转诊至泌尿外科。对于局限于肾脏的 RCC,治疗方案包括肾部分切除术或根治性肾切除术、消融技术(如低温消融、射频消融、放射治疗),或对部分患者(尤其是有肾肿块的患者)进行积极监测,并进行相关治疗:RCC 是一种常见的恶性肿瘤,通常在腹部造影检查中偶然被诊断出来。70%的患者被诊断为 RCC I 期,11%的患者为 IV 期。早期 RCC 的一线治疗方法包括部分或根治性肾切除术(可使 5 年癌症特异性生存率超过 94%)、消融技术或积极监测。转移性 RCC 患者的新治疗方案包括免疫检查点抑制剂和酪氨酸激酶抑制剂。
{"title":"Renal Cell Carcinoma: A Review.","authors":"Tracy L Rose, William Y Kim","doi":"10.1001/jama.2024.12848","DOIUrl":"10.1001/jama.2024.12848","url":null,"abstract":"<p><strong>Importance: </strong>Renal cell carcinoma (RCC) is a common malignancy, with an estimated 434 840 incident cases worldwide in 2022. In the US, it is the sixth most common cancer among males and ninth among females.</p><p><strong>Observations: </strong>Clear cell RCC is the most common histologic subtype (75%-80% of cases) and is characterized by inactivation of the von Hippel Lindau (VHL) tumor suppressor gene. Many patients (37%-61%) are diagnosed with RCC incidentally on an abdominal imaging study such as ultrasound or computed tomographic scan, and 70% of patients have stage I RCC at diagnosis. Although its incidence has increased approximately 1% per year from 2015 through 2019, the mortality rate of RCC has declined about 2% per year in the US from 2016 through 2020. Patients with a solid renal mass or complex cystic renal mass should be referred to urology. Treatment options for RCC confined to the kidney include surgical resection with partial or radical nephrectomy, ablative techniques (eg, cryoablation, radiofrequency ablation, radiation), or active surveillance for some patients (especially those with renal masses <2 cm). For patients with renal masses less than 4 cm in size (48% of patients), partial nephrectomy can result in a 5-year cancer-specific survival of more than 94%. For advanced or metastatic RCC, combinations of immune checkpoint inhibitors or the combination of immune checkpoint inhibitors with tyrosine kinase inhibitors are associated with tumor response of 42% to 71%, with a median overall survival of 46 to 56 months.</p><p><strong>Conclusions and relevance: </strong>RCC is a common malignancy that is often diagnosed incidentally on an abdominal imaging study. Seventy percent of patients are diagnosed with stage I RCC and 11% of patients with stage IV. First-line treatments for early-stage RCC are partial or radical nephrectomy, which can result in 5-year cancer-specific survival of more than 94%, ablative techniques, or active surveillance. New treatment options for patients with metastatic RCC include immune checkpoint inhibitors and tyrosine kinase inhibitors.</p>","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
APOL1 Variant and Kidney Disease. APOL1 变异与肾病
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.14358
Constance B Hilliard
{"title":"APOL1 Variant and Kidney Disease.","authors":"Constance B Hilliard","doi":"10.1001/jama.2024.14358","DOIUrl":"10.1001/jama.2024.14358","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residency Match for Applicants With Disability-Reply. 残疾申请人的住院配对-回复。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.14415
Mytien Nguyen, Lisa M Meeks, Dowin Boatright
{"title":"Residency Match for Applicants With Disability-Reply.","authors":"Mytien Nguyen, Lisa M Meeks, Dowin Boatright","doi":"10.1001/jama.2024.14415","DOIUrl":"10.1001/jama.2024.14415","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of Historic Famine Strengthens Link Between Prenatal Malnutrition and Type 2 Diabetes. 对历史性饥荒的研究加强了产前营养不良与 2 型糖尿病之间的联系。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.15891
Samantha Anderer
{"title":"Study of Historic Famine Strengthens Link Between Prenatal Malnutrition and Type 2 Diabetes.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.15891","DOIUrl":"10.1001/jama.2024.15891","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHO Warns of Carbapenem-Resistant Hypervirulent Klebsiella pneumonia. 世卫组织警告耐碳青霉烯类抗生素的超病毒性克雷伯氏肺炎。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.15884
Samantha Anderer
{"title":"WHO Warns of Carbapenem-Resistant Hypervirulent Klebsiella pneumonia.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.15884","DOIUrl":"10.1001/jama.2024.15884","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychedelic Therapy Scrutinized by FDA Advisory Committee? 美国食品和药物管理局咨询委员会审查迷幻疗法?
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-24 DOI: 10.1001/jama.2024.13370
Mason Marks
{"title":"Psychedelic Therapy Scrutinized by FDA Advisory Committee?","authors":"Mason Marks","doi":"10.1001/jama.2024.13370","DOIUrl":"10.1001/jama.2024.13370","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":null,"pages":null},"PeriodicalIF":63.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jama-Journal of the American Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1